DST and TRH stimulation test in mood disorder subtypes
American Journal of PsychiatryPublished 1 April 1987
Alan B. Levy, Stephen L. Stern
Citations23
SJR quartileQ1
SJR score5.27
SNIP3.68
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Postdexamethasone cortisol levels but not the change in thyroid-stimulating hormone discriminated the patients with endogenous delusional depression from those with endogenous nondelusional depression.
Abstract
Both the dexamethasone suppression test (DST) and the thyrotropin-releasing hormone (TRH) stimulation test have been reported to be useful in subtyping some depression diagnoses. Whether the DST discriminates delusional from nondelusional depression remains controversial, but this possibility has not been studied for the TRH test. The authors evaluated DST and TRH test results in 29 depressed hospitalized patients; both tests significantly discriminated patients with nonendogenous depression from those with endogenous depression. Furthermore, postdexamethasone cortisol levels but not the change in thyroid-stimulating hormone discriminated the patients with endogenous delusional depression from those with endogenous nondelusional depression.
Keywords
MedicineNeuroscience
Archives of General PsychiatryA Specific Laboratory Test for the Diagnosis of Melancholia
2,249 Citations1981Bernard J. Carroll
Abnormal DST results were found with similar frequency among outpatients and inpatients with melancholia; but they were not related to age, sex, recent use of psychotropic drugs, or severity of depressive symptoms.
Archives of General PsychiatryNeuroendocrine Regulation in Depression
627 Citations1976Bernard J. Carroll
The dexamethasone suppression test may be of value as a laboratory aid in the diagnosis of "endogenous" depression as indicated by high baseline midnight plasma cortisol levels.
American Journal of PsychiatrySerum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review
502 Citations1982Peter T. Loosen, Arthur J. Prange
Present data allow some tentative conclusions that the fault usually reflects a defect in central regulation of the pituitary-thyroid axis, and in some patients the fault may be a trait marker, and it may represent a biological bridge between some depressed patients and some patients with other mental disorders.
American Journal of PsychiatryPsychiatric implications of basic and clinical studies with corticotropin-releasing factor
481 Citations1984P W Gold, George P. Chrousos +7 more
Clinically, experience in administering ovine CRF shows that CRF can be helpful in resolving differential diagnostic dilemmas in patients with various disorders of the hypothalamic-pituitary-adrenal axis and in furthering an understanding of the pathophysiology of conditions such as Cushing's disease and depression.
American Journal of PsychiatryThe pharmacological treatment of delusional depression
360 Citations1985Duane G. Spiker, Judy Weiss +7 more
The authors investigated the pharmacological treatment of delusional depression by assigning patients on a random double-blind basis to amitriptyline alone, perphenazine alone, or a combination of the two.
Journal of Psychiatric ResearchA corticosteroid/dopamine hypothesis for psychotic depression and related states
245 Citations1985Alan F. Schatzberg, Anthony J. Rothschild +3 more
It is proposed that glucocorticoids' enhancement of dopaminergic activity may explain the development of psychosis/delusions in the context of the depressive episode and these interactions have implications for understanding the biology of corticosteroid-induced psychoses in medical patients and some of the psychiatric complications of Cushing's Disease.
Journal of Clinical InvestigationInhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones
204 Citations1972Peter J. Snyder, Robert D. Utiger
The extreme sensitivity of TRH-induced TSH release to inhibition by the chronic treatment with small quantities of triiodothyronine and thyroxine which do not raise serum T(3) and T(4) levels above the normal ranges is demonstrated.
American Journal of PsychiatryThe dexamethasone suppression test: identification of subtypes of depression
157 Citations1983Alan F. Schatzberg, Anthony J. Rothschild +7 more
The distribution of values in the major depression group suggested the existence of three major subgroups, and patients with very high cortisol levels tended to fulfill criteria for major depression with mood-congruent psychosis.
American Journal of PsychiatryThe dexamethasone suppression test in the clinical setting
90 Citations1983Evans Dl, Burnett Gb +1 more
There was no difference in the rate of nonsuppression between the patients with subgroups of major depression, but those with major depression and psychosis had significantly higher postdexamethasone cortisol levels than those withMajor depression with and without melancholia and those with diagnoses other than major depression.
Journal of Affective DisordersDelusional depression*Phenomenology, neuroendocrine function, and tricyclic antidepressant response
59 Citations1984William A. Nelson, Aman Ullah Khan +1 more
Comparison in clinical variables, family history, cortisol secretion, and 4-week tricyclic antidepressant response in 13 delusional and 12 non-delusional, hospitalized depressives revealed more family history of depression but less of alcoholism, greater frequency of cortisol hypersecretion, and poorer response to tricyCLics in the delusional group.
PubMedPatient care--who pays, and for what?
46 Citations1983A. John Rush
The DST and TRH stimulation test (TRHST) was administered to 68 depressed in- and outpatients and indicated that the TRHST differentiated RDC endogenous from nonendogenous unipolar subtypes at the 5 but not the 7 IuU/ml threshold.
Journal of Affective DisordersNeuroendocrine studies in affective disorders
44 Citations1980Alec Coppen, V. A. Rama Rao +3 more
The results do not provide any strong evidence to suggest that central 5-HT mechanisms as measured by the prolactin response to thyrotropin-releasing hormone are abnormal in depressed patients or bipolar patients undergoing a manic phase.
Psychiatry ResearchEffects of antidepressant withdrawal on the dexamethasone suppression test
41 Citations1985Steven C. Dilsaver, John F. Greden
Postdexamethasone cortisol concentrations were significantly higher during the antidepressant withdrawal phase, and drug-withdrawal subjects also had an increased frequency of DST nonsuppression.
Archives of General PsychiatryPlasma Cortisol Determination for the Dexamethasone Suppression Test
40 Citations1985James Ritchie
Each laboratory should validate its own criterion cortisol value for depression based on local data, including appropriate control groups, and their importance to the clinical utility of the DST are emphasized.
Biological PsychiatryRelationships of the dexamethasone suppression test to clinical severity and degree of melancholia
38 Citations1986Anand Kumar, Kirsten H. Alcser +2 more
Maximum postdexamethasone plasma cortisol levels reflect overall severity of depression and endogeneity and that endogeneity per se is highly confounded with severity.
Journal of Affective DisordersThe dexamethasone suppression test in delusional depression
7 Citations1985JoséL. Ayuso-Gutierrez, Maria Isabel Almoguera +3 more